Tag: #USManufacturing
-
America’s 100% Drug Import Tariff — Reshaping Pharma, Patents and Patients
On September 25, 2025, the White House announced a 100% tariff on imported branded and patented drugs. This policy aims to push pharmaceutical manufacturing back to the U.S. while sparking debate among domestic firms, foreign drugmakers, and patient advocates about costs, supply, and innovation.